Articles Archives - Page 485 of 746

ThursdayDec 17, 2020 2:27 pm

Knightscope’s AI-enhanced Security Robots Address Concerns Surrounding Business Protection Industry

Knightscope is a private industry security robot developer pioneering autonomous solutions to many long-standing concerns with corporate facility protection These robots’ ability to perform repetitive, often boring and sometimes dangerous tasks makes them ideally suited for property patrolling, and their capacity for analyzing and recording their interactions qualifies them for actual crime prevention and reporting Knightscope’s models include stationary, indoor mobile and outdoor mobile machines that are outfitted with technological features including 360-degree eye-level HD streaming video, face and license plate recognition, and infrared thermal detection Sales promotion of the K5 has showcased its competitiveness by presenting its profile in…

ThursdayDec 17, 2020 1:47 pm

Pure Extract Technologies (CSE: PULL) Provides Update on Expansion into Functional Mushrooms Sector

Pure Extracts Technologies recently provided update into its expansion into functional mushrooms sector Functional mushrooms have enjoyed surge in popularity as of late, are increasingly being used in wide variety of healthcare, pharmaceutical products Functional mushrooms sector is expected to grow to annual market value of $34.4 billion by 2024 Pure Extracts plans to develop high bio-available products derived from functional mushrooms through use of its proprietary extraction processes Company also set to launch its own branded functional mushrooms-based products under ‘Pure Mushrooms’ brand from Q1 2021 onwards and has signed a LOI with the PURICA(TM) brand of mushroom wellness…

ThursdayDec 17, 2020 1:33 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Makes it Easier to See the Invisible in Cancer Surgery

Imagin Medical Inc. is a surgical imaging company building a platform of technological products designed to improve endoscopic surgeries through adaptable equipment that makes it easier to see anomalies such as cancerous tumors The company’s initial product launch will focus on bladder cancers visible under blue light thanks to a dye on the market that currently depends on the acquisition of expensive new equipment by hospitals Imagin’s proprietary i/Blue Imaging (TM) System resolves some of the expense and flexibility concerns expressed by urologists, which will grant surgeons the capacity to better root out cancers Imagin has announced an offering of…

ThursdayDec 17, 2020 1:09 pm

Predictive Oncology (NASDAQ: POAI) Leverages Precision Medicine Expertise to Support Oncologists, Improve Patient Outcomes

Precision medicine is emerging approach to disease prevention, treatment that incorporates individual’s distinctive characteristics. New approach allows doctors, researchers to predict more accurately which treatments may work better. Helomics’ database, largest of its kind, is comprised of ovarian, head and neck, colon and pancreas tumors. Science has discovered that thumbprints and DNA aren’t the only biological elements that make individuals unique. In fact, ears, eyes, tongues and even the way a person walks is distinctive, unlike anybody else in the world (https://ibn.fm/SJX27). Moreover, the things that make people different from each other don’t stop at physical characteristics. Predictive Oncology (NASDAQ:…

WednesdayDec 16, 2020 3:47 pm

HempFusion Wellness Optimistic that Hemp / CBD Market Recovery is on the Horizon

HempFusion Wellness, Inc. is developing nutritional products (currently 46 on retail store shelves) that promote overall health and wellness in a variety of ways including skin care, pain relief and gut support The company’s products are distributed to about 4,000 retailers in all 50 states as well as some international outlets, including major food and drug retailers and big box stores mostly not available to other CBD companies HempFusion has filed a preliminary prospectus for a planned initial public offering (“IPO”) on Canada’s most senior stock exchange, the TSX Market watchers expect the CBD industry to expand to $12.4 billion…

WednesdayDec 16, 2020 1:37 pm

Anticipating Significant 2021 Growth, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) Announces Major Uplisting Plans

Company plans to first uplist to TSX from its current TSX.V listing. Uplisting benefits include enhanced visibility and potentially increased access to capital If TSX uplisting is successful, Loop has plans for a possible dual listing by filing with the SEC and NASDAQ Company anticipates significant growth to continue in 2021, following an increase in demand for its products and services, resulting in higher sales, customer acquisitions, partnerships, technology stack and deployments New proprietary technology, Uklipz, is expected to launch in January 2021, joining the company’s current lineup of IoT and AI products Loop Insights (TSX.V: MTRX) (OTCQB: RACMF), an…

WednesdayDec 16, 2020 12:41 pm

Traditional Chinese Medicine Takes Root in Western Culture with Rritual Superfoods Product Line

Rritual Superfoods, Inc., is a budding new superfood developer aiming to improve people’s overall wellness with purposefully designed elixirs pairing acclaimed mushroom varieties with adaptogenic herbs The company was organized earlier this year and has launched three initial product varieties using the Chaga, Reishi and Lion’s Mane mushrooms in tandem with adaptogenic roots plus herbal spices and natural whole foods Rritual’s products are designed to help users combat stress, strengthen their immune systems and enhance their mental clarity The nascent functional mushroom market is expected to grow with a CAGR of 8.04 percent between 2019 and 2024, according to Mordor…

TuesdayDec 15, 2020 2:55 pm

Using AI-Powered Models and Drug-Response Data, Predictive Oncology (NASDAQ: POAI) Holds Strong Position in Burgeoning Precision Oncology Industry

Precision oncology leverages the profile of genetic mutations in patients for the purpose of delivering precision drug-based cancer therapy Precision oncology industry forecast to be worth 99.72 billion by 2027 according to recent report POAI applies AI to proprietary data trove, aiding oncologists in personalizing cancer therapies in addition to collaborating with pharmaceutical companies for drug discovery Precision oncology is driven by the profile of genetic mutations in tumors that give practitioners required information to target therapies based off the specific mutations in the patient’s tumor. According to a recent research report, the industry is predicted to be worth 99.72…

TuesdayDec 15, 2020 2:13 pm

Energy Fuels (NYSE American: UUUU) (TSX: EFR) Has Critical Mineral Portfolio Unlike Any Other

"Energy Fuels will always, first and foremost, be a uranium producer,” says CEO Company is playing it smart with financial stability, scalable production and additional revenue streams that utilize existing facilities Additional revenue streams include rare earth elements, vanadium, uranium recycling, and land clean-up Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company that supplies major nuclear utilities and is making huge moves into the rare earth elements (“REE”) space, is debt free and boasts diverse cash-flow-generating opportunities. In addition to uranium and REEs, the company produces vanadium, recycles uranium-bearing products and participates in land clean-up…

TuesdayDec 15, 2020 1:41 pm

Cybin Inc. (NEO: CYBN) on Right Path; Johns Hopkins Study Shows Psilocybin Positive Impact on Major Depression

Study published in “JAMA Psychiatry” reveals significant benefits of psilocybin for patients with major depression Most participants reported improvements; half experienced remission after only four weeks As an early entrant in the field, Cybin looks well placed to capitalize on growing traction that psychedelics gain as potential treatment of mental health conditions Only two doses of psilocybin accompanied with psychotherapy may lead to significant reductions in depressive symptoms in adults with major depression, according to recent research conducted by Johns Hopkins Medicine and published in “JAMA Psychiatry” (https://ibn.fm/AM1Ww). As a leading life sciences company focused on psychedelic drug development, Cybin…

Site Search

Company Search

Category: Articles